Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
14,731
archived clinical trials in
Psychiatric

A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated:  2/2/2017
Clinical Research Facility
2475
mi
from 98109
Lexington, MA
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated: 2/2/2017
Clinical Research Facility
2475
mi
from 98109
Lexington, MA
Click here to add this to my saved trials
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated:  2/2/2017
Clinical Research Facility
1393
mi
from 98109
Minneapolis, MN
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated: 2/2/2017
Clinical Research Facility
1393
mi
from 98109
Minneapolis, MN
Click here to add this to my saved trials
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated:  2/2/2017
Clinical Research Facility
2402
mi
from 98109
Bronx, NY
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated: 2/2/2017
Clinical Research Facility
2402
mi
from 98109
Bronx, NY
Click here to add this to my saved trials
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated:  2/2/2017
Clinical Research Facility
2400
mi
from 98109
New York, NY
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated: 2/2/2017
Clinical Research Facility
2400
mi
from 98109
New York, NY
Click here to add this to my saved trials
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated:  2/2/2017
Clinical Research Facility
2393
mi
from 98109
Orangeburg, NY
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated: 2/2/2017
Clinical Research Facility
2393
mi
from 98109
Orangeburg, NY
Click here to add this to my saved trials
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated:  2/2/2017
Clinical Research Facility
2341
mi
from 98109
Durham, NC
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated: 2/2/2017
Clinical Research Facility
2341
mi
from 98109
Durham, NC
Click here to add this to my saved trials
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated:  2/2/2017
Clinical Research Facility
1967
mi
from 98109
Cincinnati, OH
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated: 2/2/2017
Clinical Research Facility
1967
mi
from 98109
Cincinnati, OH
Click here to add this to my saved trials
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated:  2/2/2017
Clinical Research Facility
2020
mi
from 98109
Cleveland, OH
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated: 2/2/2017
Clinical Research Facility
2020
mi
from 98109
Cleveland, OH
Click here to add this to my saved trials
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated:  2/2/2017
Clinical Research Facility
2132
mi
from 98109
Pittsburgh, PA
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated: 2/2/2017
Clinical Research Facility
2132
mi
from 98109
Pittsburgh, PA
Click here to add this to my saved trials
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated:  2/2/2017
Clinical Research Facility
1970
mi
from 98109
Nashville, TN
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated: 2/2/2017
Clinical Research Facility
1970
mi
from 98109
Nashville, TN
Click here to add this to my saved trials
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated:  2/2/2017
Clinical Research Facility
1790
mi
from 98109
San Antonio, TX
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated: 2/2/2017
Clinical Research Facility
1790
mi
from 98109
San Antonio, TX
Click here to add this to my saved trials
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated:  2/2/2017
Clinical Research Facility
9
mi
from 98109
Bellevue, WA
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated: 2/2/2017
Clinical Research Facility
9
mi
from 98109
Bellevue, WA
Click here to add this to my saved trials
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated:  2/2/2017
Clinical Research Facility
10
mi
from 98109
Bothell, WA
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated: 2/2/2017
Clinical Research Facility
10
mi
from 98109
Bothell, WA
Click here to add this to my saved trials
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated:  2/2/2017
Clinical Research Facility
2
mi
from 98109
Seattle, WA
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated: 2/2/2017
Clinical Research Facility
2
mi
from 98109
Seattle, WA
Click here to add this to my saved trials
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated:  2/2/2017
Southwest Autism Research and Resource Center
1115
mi
from 98109
Phoenix, AZ
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated: 2/2/2017
Southwest Autism Research and Resource Center
1115
mi
from 98109
Phoenix, AZ
Click here to add this to my saved trials
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated:  2/2/2017
University of California-Davis
627
mi
from 98109
Sacramento, CA
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated: 2/2/2017
University of California-Davis
627
mi
from 98109
Sacramento, CA
Click here to add this to my saved trials
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated:  2/2/2017
PCSD - Feighner Research
1065
mi
from 98109
San Diego, CA
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated: 2/2/2017
PCSD - Feighner Research
1065
mi
from 98109
San Diego, CA
Click here to add this to my saved trials
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated:  2/2/2017
University of California at San Francisco
682
mi
from 98109
San Francisco, CA
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated: 2/2/2017
University of California at San Francisco
682
mi
from 98109
San Francisco, CA
Click here to add this to my saved trials
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated:  2/2/2017
DBA IMMUNOe Int'l Res Center
1031
mi
from 98109
Centennial, CO
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated: 2/2/2017
DBA IMMUNOe Int'l Res Center
1031
mi
from 98109
Centennial, CO
Click here to add this to my saved trials
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated:  2/2/2017
Yale University; Yale Child Study Center
2432
mi
from 98109
New Haven, CT
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated: 2/2/2017
Yale University; Yale Child Study Center
2432
mi
from 98109
New Haven, CT
Click here to add this to my saved trials
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated:  2/2/2017
Neurology offices of south florida
2703
mi
from 98109
Delray Beach, FL
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated: 2/2/2017
Neurology offices of south florida
2703
mi
from 98109
Delray Beach, FL
Click here to add this to my saved trials
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated:  2/2/2017
Research Centers of America, LLC
2713
mi
from 98109
Oakland Park, FL
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated: 2/2/2017
Research Centers of America, LLC
2713
mi
from 98109
Oakland Park, FL
Click here to add this to my saved trials
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated:  2/2/2017
Compass Research LLC
2547
mi
from 98109
Orlando, FL
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated: 2/2/2017
Compass Research LLC
2547
mi
from 98109
Orlando, FL
Click here to add this to my saved trials
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated:  2/2/2017
Emory University School of Medicine; Department of Human Genetics & Pediatrics
2181
mi
from 98109
Decatur, GA
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated: 2/2/2017
Emory University School of Medicine; Department of Human Genetics & Pediatrics
2181
mi
from 98109
Decatur, GA
Click here to add this to my saved trials
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated:  2/2/2017
Rush University Medical Center
1730
mi
from 98109
Chicago, IL
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated: 2/2/2017
Rush University Medical Center
1730
mi
from 98109
Chicago, IL
Click here to add this to my saved trials
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated:  2/2/2017
Kennedy Krieger Institute
2329
mi
from 98109
Baltimore, MD
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated: 2/2/2017
Kennedy Krieger Institute
2329
mi
from 98109
Baltimore, MD
Click here to add this to my saved trials
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated:  2/2/2017
Neuroscientific Insights
2310
mi
from 98109
Rockville, MD
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated: 2/2/2017
Neuroscientific Insights
2310
mi
from 98109
Rockville, MD
Click here to add this to my saved trials
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated:  2/2/2017
Massachusetts General Hospital
2475
mi
from 98109
Lexington, MA
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated: 2/2/2017
Massachusetts General Hospital
2475
mi
from 98109
Lexington, MA
Click here to add this to my saved trials
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated:  2/2/2017
University of Minnesota; Clin. Neuro Research Unit
1393
mi
from 98109
Minneapolis, MN
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated: 2/2/2017
University of Minnesota; Clin. Neuro Research Unit
1393
mi
from 98109
Minneapolis, MN
Click here to add this to my saved trials
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated:  2/2/2017
Montefiore Medical Center; Departments of Psychiatry & Biobehavioral Science
2402
mi
from 98109
Bronx, NY
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated: 2/2/2017
Montefiore Medical Center; Departments of Psychiatry & Biobehavioral Science
2402
mi
from 98109
Bronx, NY
Click here to add this to my saved trials
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated:  2/2/2017
Mount Sinai School of Medicine - Seaver Autism Center
2402
mi
from 98109
New York, NY
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated: 2/2/2017
Mount Sinai School of Medicine - Seaver Autism Center
2402
mi
from 98109
New York, NY
Click here to add this to my saved trials
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated:  2/2/2017
Nathan S. Kline Institute for Psychiatric Research
2393
mi
from 98109
Orangeburg, NY
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated: 2/2/2017
Nathan S. Kline Institute for Psychiatric Research
2393
mi
from 98109
Orangeburg, NY
Click here to add this to my saved trials
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated:  2/2/2017
DUKE SCHOOL OF MEDICINE;Duke Center for Autism and Brain Development
2338
mi
from 98109
Durham, NC
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated: 2/2/2017
DUKE SCHOOL OF MEDICINE;Duke Center for Autism and Brain Development
2338
mi
from 98109
Durham, NC
Click here to add this to my saved trials
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated:  2/2/2017
Cincinnati Children's Hospital Medical Center
1966
mi
from 98109
Cincinnati, OH
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated: 2/2/2017
Cincinnati Children's Hospital Medical Center
1966
mi
from 98109
Cincinnati, OH
Click here to add this to my saved trials
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated:  2/2/2017
University Hospitals
2024
mi
from 98109
Cleveland, OH
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated: 2/2/2017
University Hospitals
2024
mi
from 98109
Cleveland, OH
Click here to add this to my saved trials
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated:  2/2/2017
UPMC Western Psychiatric Institute and Clinic
2134
mi
from 98109
Pittsburgh, PA
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated: 2/2/2017
UPMC Western Psychiatric Institute and Clinic
2134
mi
from 98109
Pittsburgh, PA
Click here to add this to my saved trials
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated:  2/2/2017
Vanderbilt Medical Center
1971
mi
from 98109
Nashville, TN
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated: 2/2/2017
Vanderbilt Medical Center
1971
mi
from 98109
Nashville, TN
Click here to add this to my saved trials
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated:  2/2/2017
Road Runner Research
1774
mi
from 98109
San Antonio, TX
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated: 2/2/2017
Road Runner Research
1774
mi
from 98109
San Antonio, TX
Click here to add this to my saved trials
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated:  2/2/2017
Northwest Clinical Research Center
9
mi
from 98109
Bellevue, WA
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated: 2/2/2017
Northwest Clinical Research Center
9
mi
from 98109
Bellevue, WA
Click here to add this to my saved trials
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated:  2/2/2017
Pacific Institute of Medical Sciences
10
mi
from 98109
Bothell, WA
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated: 2/2/2017
Pacific Institute of Medical Sciences
10
mi
from 98109
Bothell, WA
Click here to add this to my saved trials
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated:  2/2/2017
Seattle Children'S Research Institute
2
mi
from 98109
Seattle, WA
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated: 2/2/2017
Seattle Children'S Research Institute
2
mi
from 98109
Seattle, WA
Click here to add this to my saved trials
Ketamine for Suicidality in Bipolar Depression
Ketamine vs. Midazolam in Bipolar Depression
Status: Enrolling
Updated:  2/6/2017
Columbia University/New York State Psychiatric Institute
2400
mi
from 98109
New York, NY
Ketamine for Suicidality in Bipolar Depression
Ketamine vs. Midazolam in Bipolar Depression
Status: Enrolling
Updated: 2/6/2017
Columbia University/New York State Psychiatric Institute
2400
mi
from 98109
New York, NY
Click here to add this to my saved trials
18F-AV-1451 and Florbetapir F 18 PET Imaging in Subjects at Risk for Chronic Traumatic Encephalopathy
18F-AV-1451 and Florbetapir F 18 PET Imaging in Subjects With Repetitive Brain Trauma at High Risk for Chronic Traumatic Encephalopathy
Status: Enrolling
Updated:  2/8/2017
Banner Alzheimer'S Institute
1115
mi
from 98109
Phoenix, AZ
18F-AV-1451 and Florbetapir F 18 PET Imaging in Subjects at Risk for Chronic Traumatic Encephalopathy
18F-AV-1451 and Florbetapir F 18 PET Imaging in Subjects With Repetitive Brain Trauma at High Risk for Chronic Traumatic Encephalopathy
Status: Enrolling
Updated: 2/8/2017
Banner Alzheimer'S Institute
1115
mi
from 98109
Phoenix, AZ
Click here to add this to my saved trials
18F-AV-1451 and Florbetapir F 18 PET Imaging in Subjects at Risk for Chronic Traumatic Encephalopathy
18F-AV-1451 and Florbetapir F 18 PET Imaging in Subjects With Repetitive Brain Trauma at High Risk for Chronic Traumatic Encephalopathy
Status: Enrolling
Updated:  2/8/2017
Boston University
2485
mi
from 98109
Boston, MA
18F-AV-1451 and Florbetapir F 18 PET Imaging in Subjects at Risk for Chronic Traumatic Encephalopathy
18F-AV-1451 and Florbetapir F 18 PET Imaging in Subjects With Repetitive Brain Trauma at High Risk for Chronic Traumatic Encephalopathy
Status: Enrolling
Updated: 2/8/2017
Boston University
2485
mi
from 98109
Boston, MA
Click here to add this to my saved trials
An fMRI Study on Temporal Discounting in Bipolar Disorder
Reconceptualizing Suicide as Impaired Temporal Discounting: an fMRI Study in Bipolar Disorder
Status: Enrolling
Updated:  2/8/2017
Bipolar Clinic and Research Program at Massachusetts General Hospital
2485
mi
from 98109
Boston, MA
An fMRI Study on Temporal Discounting in Bipolar Disorder
Reconceptualizing Suicide as Impaired Temporal Discounting: an fMRI Study in Bipolar Disorder
Status: Enrolling
Updated: 2/8/2017
Bipolar Clinic and Research Program at Massachusetts General Hospital
2485
mi
from 98109
Boston, MA
Click here to add this to my saved trials
Pharmacology of Cognition in Schizotypal Personality Disorder
Pharmacology of Cognition in Schizotypal Personality Disorder: Guanfacine for Cognitive Symptoms in Schizotypal Personality Disorder
Status: Enrolling
Updated:  2/9/2017
Icahn School of Medicine at Mount Sinai
mi
from 98109
New York, NY
Pharmacology of Cognition in Schizotypal Personality Disorder
Pharmacology of Cognition in Schizotypal Personality Disorder: Guanfacine for Cognitive Symptoms in Schizotypal Personality Disorder
Status: Enrolling
Updated: 2/9/2017
Icahn School of Medicine at Mount Sinai
mi
from 98109
New York, NY
Click here to add this to my saved trials
Two Stepped Care Models for Posttraumatic Stress Disorder (PTSD) Among Cambodian Refugees With PTSD
Two Stepped Care Models for PTSD Among Cambodian Refugees With PTSD
Status: Enrolling
Updated:  2/9/2017
Massachusetts General Hospital
2485
mi
from 98109
Boston, MA
Two Stepped Care Models for Posttraumatic Stress Disorder (PTSD) Among Cambodian Refugees With PTSD
Two Stepped Care Models for PTSD Among Cambodian Refugees With PTSD
Status: Enrolling
Updated: 2/9/2017
Massachusetts General Hospital
2485
mi
from 98109
Boston, MA
Click here to add this to my saved trials
Cannabidiol and Emotional Stimuli
Effects of Cannabidiol on Responses to Emotional Stimuli
Status: Enrolling
Updated:  2/9/2017
University of Chicago
1737
mi
from 98109
Chicago, IL
Cannabidiol and Emotional Stimuli
Effects of Cannabidiol on Responses to Emotional Stimuli
Status: Enrolling
Updated: 2/9/2017
University of Chicago
1737
mi
from 98109
Chicago, IL
Click here to add this to my saved trials
Online Parent Training for Children With Behavior Disorders
Online Parent Training for Children With Behavior Disorders: Phase II
Status: Enrolling
Updated:  2/13/2017
Oregon Research Institute
151
mi
from 98109
Portland, OR
Online Parent Training for Children With Behavior Disorders
Online Parent Training for Children With Behavior Disorders: Phase II
Status: Enrolling
Updated: 2/13/2017
Oregon Research Institute
151
mi
from 98109
Portland, OR
Click here to add this to my saved trials
Post Anesthesia Emergence and Behavioral Changes in Children Undergoing MRI
Post Anesthesia Emergence and Behavioral Changes in Children Undergoing MRI: Comparative Study Using Propofol, Sevoflurane and Isoflurane
Status: Enrolling
Updated:  2/13/2017
Women and Chidren's Hospital Of Buffalo
2110
mi
from 98109
Buffalo, NY
Post Anesthesia Emergence and Behavioral Changes in Children Undergoing MRI
Post Anesthesia Emergence and Behavioral Changes in Children Undergoing MRI: Comparative Study Using Propofol, Sevoflurane and Isoflurane
Status: Enrolling
Updated: 2/13/2017
Women and Chidren's Hospital Of Buffalo
2110
mi
from 98109
Buffalo, NY
Click here to add this to my saved trials